The blockade onset times and durations after epidural administration of 8% emulsified isoflurane (v/v) or 1% lidocaine. Values are means (sd) (n=10). *P<0.01 vs Lidocaine group
Drug administered (1 ml) . | 8% emulsified isoflurane (E-isoflurane group) . | 1% lidocaine (Lidocaine group) . |
---|---|---|
Sensory blockade | ||
Onset (min) | 1.4 (0.7) | 1.3 (0.5) |
Duration (min) | 68 (13)* | 49 (13) |
Motor blockade | ||
Onset (min) | 1.6 (0.7) | 1.7 (0.8) |
Duration (min) | 38 (8) | 34 (10) |
Maximum blockade onset | ||
Sensory (min) | 4.2 (1.6) | 3.9 (1.4) |
Motor (min) | 3.5 (1.0) | 3.7 (1.4) |
Drug administered (1 ml) . | 8% emulsified isoflurane (E-isoflurane group) . | 1% lidocaine (Lidocaine group) . |
---|---|---|
Sensory blockade | ||
Onset (min) | 1.4 (0.7) | 1.3 (0.5) |
Duration (min) | 68 (13)* | 49 (13) |
Motor blockade | ||
Onset (min) | 1.6 (0.7) | 1.7 (0.8) |
Duration (min) | 38 (8) | 34 (10) |
Maximum blockade onset | ||
Sensory (min) | 4.2 (1.6) | 3.9 (1.4) |
Motor (min) | 3.5 (1.0) | 3.7 (1.4) |
The blockade onset times and durations after epidural administration of 8% emulsified isoflurane (v/v) or 1% lidocaine. Values are means (sd) (n=10). *P<0.01 vs Lidocaine group
Drug administered (1 ml) . | 8% emulsified isoflurane (E-isoflurane group) . | 1% lidocaine (Lidocaine group) . |
---|---|---|
Sensory blockade | ||
Onset (min) | 1.4 (0.7) | 1.3 (0.5) |
Duration (min) | 68 (13)* | 49 (13) |
Motor blockade | ||
Onset (min) | 1.6 (0.7) | 1.7 (0.8) |
Duration (min) | 38 (8) | 34 (10) |
Maximum blockade onset | ||
Sensory (min) | 4.2 (1.6) | 3.9 (1.4) |
Motor (min) | 3.5 (1.0) | 3.7 (1.4) |
Drug administered (1 ml) . | 8% emulsified isoflurane (E-isoflurane group) . | 1% lidocaine (Lidocaine group) . |
---|---|---|
Sensory blockade | ||
Onset (min) | 1.4 (0.7) | 1.3 (0.5) |
Duration (min) | 68 (13)* | 49 (13) |
Motor blockade | ||
Onset (min) | 1.6 (0.7) | 1.7 (0.8) |
Duration (min) | 38 (8) | 34 (10) |
Maximum blockade onset | ||
Sensory (min) | 4.2 (1.6) | 3.9 (1.4) |
Motor (min) | 3.5 (1.0) | 3.7 (1.4) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.